BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 34702278)

  • 1. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
    Sun D; Yang KS; Chen JL; Wang ZB
    World J Surg Oncol; 2021 Oct; 19(1):314. PubMed ID: 34702278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
    Yang M; He H; Peng T; Lu Y; Yu J
    Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Prognosis-Related RNA-Binding Proteins to Reveal the Role of RNA-Binding Proteins in the Progression and Prognosis of Colon Cancer.
    Ding Y; Fang L; Yang XP; Zou Q
    Int J Gen Med; 2021; 14():6795-6805. PubMed ID: 34703285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA.
    Cao L; Duan L; Zhang R; Yang W; Yang N; Huang W; Chen X; Wang N; Niu L; Zhou W; Chen J; Li Y; Zhang Y; Liu J; Fan D; Liu H
    Hereditas; 2023 Mar; 160(1):10. PubMed ID: 36895014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer.
    Zhang W; Liu T; Jiang L; Chen J; Li Q; Wang J
    Front Genet; 2022; 13():1001239. PubMed ID: 36425071
    [No Abstract]   [Full Text] [Related]  

  • 10. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer.
    Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W
    J Oncol; 2022; 2022():5468858. PubMed ID: 36467500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
    Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
    Front Immunol; 2021; 12():783362. PubMed ID: 35154072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer.
    Mo S; Pei Z; Dai L
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):163-178. PubMed ID: 33734891
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration and validation of the prognostic value of RNA-binding proteins in hepatocellular carcinoma.
    Wang J; Han K; Li Y; Zhang C; Cui WH; Zhu LH; Luo T; Bian CJ
    Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8945-8958. PubMed ID: 36524514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence.
    Xing Q; Liu S; Luan J; Wang Y; Ma L
    Pathol Res Pract; 2021 Sep; 225():153587. PubMed ID: 34419719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration.
    Xing Q; Jiaochen Luan ; Shouyong Liu ; Limin Ma ; Wang Y
    Bosn J Basic Med Sci; 2022 Jun; 22(3):435-452. PubMed ID: 34420511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
    Xu M; Li Q; Zhang J; Xie H
    Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.